JPRN-UMIN000011154已完成未知
A PHASE III RANDOMIZED TRIAL OF PULSE ACTINOMYCIN-D VERSUS MULTI-DAY METHOTREXATE FOR THE TREATMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA - GOG-0275
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
Schink JC, et al. Gynecol Oncol 2020; 158(2): 354-360
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Patients who do not have GTN as defined in Key inclusion criteria 1). 2)Patients with non-gestational choriocarcinoma. 3)Patients who have previously been treated with cytotoxic chemotherapy. However, patients who received prior low-dose methotrexate for treatment of an ectopic pregnancy will be eligible for this study. 4)Patients who have received prior pelvic radiation. 5)Patients with placental site trophoblastic tumor (PSTT) or epithelioid trophoblastic tumor (ETT). 6)Patients with GOG Performance status of 3 or 4. 7)Patients with a history of other invasive malignancies, with the exception of non-melanoma skin cancer, are excluded if there is any evidence of other malignancy being present within the last five years. Patients are also excluded if their previous cancer treatment contraindicates this protocol therapy. 8)Patients whose circumstances at the time of study entry do not permit completion of the study or required follow-up. 9)Patients who wish to breast-feed during treatment.
研究者
相似试验
已完成
3 期
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic NeoplasiaFIGO Stage I Gestational Trophoblastic TumorFIGO Stage II Gestational Trophoblastic TumorFIGO Stage III Gestational Trophoblastic TumorChoriocarcinomaHydatidiform MoleNCT01535053GOG Foundation57
已完成
3 期
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerBreast CancerNCT00431080Hellenic Oncology Research Group478
已完成
3 期
Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaAdult Malignant MesenchymomaAdult RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaChildhood Malignant MesenchymomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood RhabdomyosarcomaNonmetastatic Childhood Soft Tissue SarcomaPreviously Untreated Childhood RhabdomyosarcomaStage I Adult Soft Tissue SarcomaStage II Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaNCT00003958Children's Oncology Group702
招募中
3 期
Comparison of two drugs in the treatment of a low risk treatable malignancyCTRI/2012/11/003120Christian Medical College150
进行中（未招募）
1 期
STUDY TO DETERMINE AS EFFECTIVE AND SAFE IS THE RICH PLASMA IN GROWTH FACTORS IN THE TREATMENT OF A TYPE OF ANAL FISTULA IN COMPARISON WITH PLACEBOPatients with anal fistulaEUCTR2017-001209-34-ESFISEVI100